Related Experiment Video
Updated: Jun 4, 2025

05:06
Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
Published on: November 10, 2023
898
Metal-based smart nanosystems in cancer immunotherapy
Ying Luo1, Xiaojing He1,2, Qianying Du1
1Department of Radiology Second Affiliated Hospital of Chongqing Medical University Chongqing People's Republic of China.
Exploration (Beijing, China)
|December 23, 2024
Summary
Metal-based smart nanosystems (MSNs) offer a promising approach to cancer immunotherapy by delivering metal ions effectively. These systems overcome challenges of metal clearance and toxicity, enhancing antitumor immunity.
Area of Science:
- Nanomedicine
- Immunology
- Materials Science
Background:
- Metals show potential in cancer immunotherapy by activating immunostimulatory mechanisms.
- Free metal ions face challenges in circulation, leading to clearance and systemic toxicity.
- Metal-based smart nanosystems (MSNs) offer a solution for controlled metal ion delivery.
Purpose of the Study:
- To review the latest research on metal-related immunotherapy.
- To delineate the mechanisms of MSNs in immunotherapy.
- To discuss the applications and future directions of MSNs in cancer treatment.
Main Methods:
- Comprehensive literature review of metal-based immunotherapy and nanomedicine.
- Analysis of MSN properties, stimuli-responsiveness, and metal ion release mechanisms.
- Evaluation of MSN applications in cancer treatment and combination immunotherapy.
Main Results:
- MSNs provide controlled release of metal ions, overcoming limitations of free metal ions.
- Different MSNs exhibit unique characteristics and compositions for tailored metalloimmunotherapy.
- MSNs demonstrate potential in cancer treatment and synergistic combination immunotherapy.
Conclusions:
- MSNs are a promising platform for metalloimmunotherapy, enhancing antitumor immunity.
- Further research is needed to address challenges and optimize MSN design and application.
- Future advances in MSNs hold significant potential for improving cancer immunotherapy strategies.
Related Concept Videos
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Vaccines
338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338

